FindTrial
Sign In

Management of juvenile myopic anisometropia by1% Atropine Salfate

Management of juvenile myopic anisometropia by1% Atropine Salfate

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-12001931
Enrollment
Unknown
Registered
2012-02-07
Start date
2011-01-07
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anisometropia

Interventions

1:1% Atropine Salfate

Sponsors

Zhongshan Ophthalmic Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
9 Years to 15 Years

Inclusion criteria

Inclusion criteria: Healthy children aged 9-15 with myopic anisometropia.

Exclusion criteria

Exclusion criteria: Obvious phsical diseases or ocular diseases

Design outcomes

Primary

MeasureTime frame
amount of anisometropi;—

Secondary

MeasureTime frame
axial length;—

Countries

China

Contacts

Public ContactYang Zhikuan
zocyang@189.cn+86 20 87330351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026